
Home » MERCK TO BUY GLYCOFI, ABMAXIS FOR $480M
MERCK TO BUY GLYCOFI, ABMAXIS FOR $480M
Pharmaceutical company Merck & Co. Inc. said Tuesday it agreed to acquire GlycoFi Inc., a privately held biotechnology company, for $400 million in cash.
Business Week (http://www.businessweek.com/ap/financialnews/D8HG9N485.htm?campaign_id=apn_home_down&chan=db)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
08Sep
-
13Sep
-
14Sep
-
15Sep
-
20Sep
-
21Sep